Three-year follow-up of previously treated patients with Waldenström Macroglobulinemia

 ABSTRACT   06/2020

For more information about this publication, please submit a medical information request.

Three-year follow-up of treatment-naive and previously treated patients with Waldenström Macroglobulinemia (WM) receiving single-agent Zanubrutinib

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service